Vandetanib-induced inhibition of neuroblastoma cell migration and invasion is associated with downregulation of the SDF-1/CXCR4 axis and matrix metalloproteinase 14

  • Authors:
    • Xionghui Ding
    • Li Xiang
    • Ning Wang
    • Zhanbo Zhao
    • Xin Jin
    • Yanhui Sun
    • Wenjuan Duan
    • Shiqi Wang
    • Xianqing Jin
  • View Affiliations

  • Published online on: December 31, 2013     https://doi.org/10.3892/or.2013.2963
  • Pages: 1165-1174
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Rearranged during transfection (RET) is widely expressed in neuroblastoma (NB) and partly contributes to high metastatic potential and survival of NB. The aim of the present study was to investigate whether vandetanib (a RET inhibitor) inhibits proliferation, migration and invasion of NB cells in vitro. The effects of vandetanib on the proliferation, apoptosis and cell cycle and on RET phosphorylation of SK-N-SH and SH-SY5Y cells were evaluated in vitro. The migration and invasion potential of vandetanib-treated NB cells were analyzed using Transwell cell migration and invasion assays, respectively. qPCR, western blotting and immunofluorescence were used to detect mRNA and protein levels in NB cells treated with vandetanib. Our data demonstrated that vandetanib inhibits the proliferation of SK-N-SH and SH-SY5Y cells and that this inhibition is mediated by the induction of G1 phase cell cycle arrest at lower concentrations and by apoptosis at higher concentrations. In the presence of vandetanib, the migration and invasion of two NB cell lines were markedly decreased compared with the control group (p<0.01). In addition, our data showed that the levels of C-X-C chemokine receptor type 4 (CXCR4) and matrix metalloproteinase 14 (MMP14) mRNA expression in NB cell lines treated with vandetanib were significantly lower than those in the cells that were treated with vehicle (p<0.01) and similar results were obtained for protein levels as determined by western blotting and immunofluorescence analysis. Vandetanib may inhibit the proliferation, migration and invasion of NB cells in vitro. The potential mechanisms for the inhibition of NB migration and invasion by vandetanib may partly be attributed to the ability of vandetanib to suppress the expression of CXCR4 and MMP14 in human NB cells.
View Figures
View References

Related Articles

Journal Cover

2014-March
Volume 31 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Ding X, Xiang L, Wang N, Zhao Z, Jin X, Sun Y, Duan W, Wang S and Jin X: Vandetanib-induced inhibition of neuroblastoma cell migration and invasion is associated with downregulation of the SDF-1/CXCR4 axis and matrix metalloproteinase 14. Oncol Rep 31: 1165-1174, 2014
APA
Ding, X., Xiang, L., Wang, N., Zhao, Z., Jin, X., Sun, Y. ... Jin, X. (2014). Vandetanib-induced inhibition of neuroblastoma cell migration and invasion is associated with downregulation of the SDF-1/CXCR4 axis and matrix metalloproteinase 14. Oncology Reports, 31, 1165-1174. https://doi.org/10.3892/or.2013.2963
MLA
Ding, X., Xiang, L., Wang, N., Zhao, Z., Jin, X., Sun, Y., Duan, W., Wang, S., Jin, X."Vandetanib-induced inhibition of neuroblastoma cell migration and invasion is associated with downregulation of the SDF-1/CXCR4 axis and matrix metalloproteinase 14". Oncology Reports 31.3 (2014): 1165-1174.
Chicago
Ding, X., Xiang, L., Wang, N., Zhao, Z., Jin, X., Sun, Y., Duan, W., Wang, S., Jin, X."Vandetanib-induced inhibition of neuroblastoma cell migration and invasion is associated with downregulation of the SDF-1/CXCR4 axis and matrix metalloproteinase 14". Oncology Reports 31, no. 3 (2014): 1165-1174. https://doi.org/10.3892/or.2013.2963